Convatec Group PLC (LON:CTEC)
London · Delayed Price · Currency is GBP · Price in GBX 238.40
-5.40 (-2.21%)
At close: Mar 9, 2026
Convatec Group Market Cap
Convatec Group has a market cap or net worth of 4.65 billion as of March 9, 2026. Its market cap has decreased by -8.03% in one year.
Market Cap
4.65B
Enterprise Value
5.72B
Revenue
1.81B
Ranking
n/a
PE Ratio
37.31
Stock Price
238.40
Market Cap Chart
Since October 26, 2016, Convatec Group's market cap has increased from 4.39B to 4.65B, an increase of 5.84%. That is a compound annual growth rate of 0.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 4.65B | -1.97% |
| Dec 31, 2025 | 4.74B | 4.77% |
| Dec 31, 2024 | 4.53B | -9.11% |
| Dec 29, 2023 | 4.98B | 4.77% |
| Dec 30, 2022 | 4.75B | 22.28% |
| Dec 31, 2021 | 3.89B | -2.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 224.89B |
| GSK plc | 81.66B |
| Haleon | 33.58B |
| Smith & Nephew | 10.92B |
| Hikma Pharmaceuticals | 2.66B |
| HUTCHMED (China) | 1.84B |
| Genus | 1.79B |
| Oxford Nanopore Technologies | 1.18B |